Charles H. Weissman

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe et al. · Journal of Thoracic Oncology · 2010 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Charles H. Weissman, Craig H. Reynolds, Marcus A. Neubauer et al. · Journal of Thoracic Oncology · 2011 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

An open-label, phase II trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel), carboplatin, and bevacizumab in first-line patients with advanced non-squamous non-small cell lung cancer (NSCLC)

C. Reynolds, David Barrera, Dennis Vu et al. · Journal of Clinical Oncology · 2007 · 15 citations

Medicine, Oncology, Pharmacology +14